Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.

Hanna WM,Hammond E,Taylor CR,Dabbs DJ,Penault-Llorca F,Bloom KJ,Bilous M,Badve S